News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Translating Omics to Diagnostic Tests: New course available by EHA
Photo taken from EHA/X
Jun 30, 2024, 14:04

Translating Omics to Diagnostic Tests: New course available by EHA

European Hematology Association (EHA) shared a post on X:     .

“New course available: Myeloid Neoplasms: Translating Omics to Diagnostic Tests.

Professor Mead addresses prognostic factors in myeloid malignancies and stratifying patient outcomes, while Professor Porkka highlights how big data could give prognostic indications.”

Additional details.
Source: EHA/X

Adam Mead cancer Diagnostic Tests EHA European Hematology Association Kimmo Porkka MPNs myeloid malignancies myeloid neoplasms OncoDaily Oncology prognostic factors in myeloid malignancies prognostic indications Translating Omics to Diagnostic Tests
Special Coverage
Science
Dec 28, 2024, 16:08
Jonathan Govette: AI in Healthcare: Bridging the Gap Between Potential and Adoption
Career
Dec 28, 2024, 16:06
Join the CCI Europe team as a Junior Projects Coordinator in Vienna
Science
Dec 28, 2024, 15:55
Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment
Science
Dec 28, 2024, 15:46
Vivek Subbiah: Our paper on the development of PROTAC degraders of oncogenic RET protein
Drugs
Dec 28, 2024, 15:46
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Blog
Dec 28, 2024, 15:14
Can clinical trials transform cancer care? - UICC
Blog
Dec 28, 2024, 14:29
Matthias Dietzel: What is the impact of prostate imaging quality?
Blog
Dec 28, 2024, 14:25
The IASLC’s Hot Topic in Basic and Translational Science: SCLC has extended the abstract submission deadline
Blog
Dec 28, 2024, 14:23
Cynthia Jordan: How to learn about and find breast cancer clinical trials
Science
Dec 28, 2024, 14:09
The new NCCN guidelines for immunotherapy-related toxicities
Blog
Dec 28, 2024, 14:04
Francisco Conesa Buendía: FAS-Less Allogeneic CAR-T Cells - A Leap Towards Off-the-Shelf Cancer Therapies
Insight
Dec 28, 2024, 13:49
Timothée Olivier: What is the best 1st line immunotherapy regimen for patients with advanced/meta melanoma?